AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 296: E812-E819, 2009. First published January 27, 2009; doi:10.1152/ajpendo.90710.2008
0193-1849/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
296/4/E812    most recent
90710.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, W. S.
Right arrow Articles by Kim, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, W. S.
Right arrow Articles by Kim, J. B.

Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity

Woo Sik Kim,1,* Yun Sok Lee,1,* Seung Hun Cha,2,* Hyun Woo Jeong,1 Sung Sik Choe,1 Mi-Ran Lee,3 Goo Taeg Oh,3 Hye-Sun Park,4 Ki-Up Lee,4 M. Daniel Lane,2 and Jae Bum Kim1

1Institute of Molecular Biology and Genetics, Seoul National University, Seoul 151-742, Korea; 2Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205; 3Division of Life and Pharmaceutical Sciences, Center for Cell Signaling Research, Ewha Womans University, Seoul 120-750; and 4Asan Institute for Life Sciences, and Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea 138-736

Submitted 17 November 2008 ; accepted in final form 26 January 2009

AMP-activated protein kinase (AMPK) plays an important role in regulating whole body energy homeostasis. Recently, it has been demonstrated that berberine (BBR) exerts antiobesity and antidiabetic effects in obese and diabetic rodent models through the activation of AMPK in peripheral tissues. Here we show that BBR improves lipid dysregulation and fatty liver in obese mice through central and peripheral actions. In obese db/db and ob/ob mice, BBR treatment reduced liver weight, hepatic and plasma triglyceride, and cholesterol contents. In the liver and muscle of db/db mice, BBR promoted AMPK activity and fatty acid oxidation and changed expression of genes involved in lipid metabolism. Additionally, intracerebroventricular administration of BBR decreased the level of malonyl-CoA and stimulated the expression of fatty acid oxidation genes in skeletal muscle. Together, these data suggest that BBR would improve fatty liver in obese subjects, which is probably mediated not only by peripheral AMPK activation but also by neural signaling from the central nervous system.

fatty acid oxidation; hypothalamus; malonyl-coenzyme A; AMP-activated protein kinase


Address for reprint requests and other correspondence: J. Bum Kim, Institute of Molecular Biology and Genetics, Dept. of Biological Sciences, Seoul National University, San 56-1, Sillim-Dong, Kwanak-Gu, Seoul 151-742, Korea (e-mail: jaebkim{at}snu.ac.kr)






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.